Daniel Schneiderman - Jun 30, 2021 Form 4 Insider Report for AzurRx BioPharma, Inc. (FWBI)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Daniel H. Schneiderman
Stock symbol
FWBI
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 05:09 PM
Next filing
Jan 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FWBI Stock option (right to buy) Other $0 -35K -100% $0.00* 0 Jun 30, 2021 Common Stock, par value $0.0001 per share 35K $0.85 Direct F1, F2
transaction FWBI Stock option (right to buy) Award $0 +35K $0.00 35K Jun 30, 2021 Common Stock, par value $0.0001 per share 35K $0.85 Direct F1, F3
transaction FWBI Stock option (right to buy) Other $0 -250K -100% $0.00* 0 Jun 30, 2021 Common Stock, par value $0.0001 per share 250K $0.85 Direct F1, F4
transaction FWBI Stock option (right to buy) Award $0 +250K $0.00 250K Jun 30, 2021 Common Stock, par value $0.0001 per share 250K $0.85 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 30, 2021, the board of directors of AzurRx BioPharma, Inc. (the "Company") rescinded and cancelled stock option awards previously made to Mr. Schneiderman on July 16, 2020 covering an aggregate of 285,006 shares under the Company's Amended and Restated 2014 Omnibus Equity Incentive Plan and granted new stock options under the Company's 2020 Omnibus Equity Incentive Plan, as amended and restated, on substantially similar terms to the rescinded stock options.
F2 The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on February 3, 2020, conditioned on Mr. Schneiderman's continued employment by the Company on the applicable vesting date.
F3 The stock option vests (i) with respect to 17,502 shares immediately and (ii) with respect to 17,504 shares over a term of 19 months in 19 equal monthly installments, conditioned on Mr. Schneiderman's continued employment by the Company on the applicable vesting date.
F4 The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on August 16, 2020, conditioned on Mr. Schneiderman's continued employment by the Company on the applicable vesting date.
F5 The stock option vests (i) with respect to 79,860 shares immediately and (ii) with respect to 170,140 shares over a term of 2 years and 1 month in 25 equal monthly installments, conditioned on Mr. Schneiderman's continued employment by the Company on the applicable vesting date.